Approximately 2.3 million Americans are affected by atrial fibrillation, the most common sustained arrhythmia. As with a lot of the conditions we highlight, the risk of atrial fibrillation increases with age. Anticoagulants have been used for years in patients with atrial fibrillation to prevent strokes, however, all types of antithrombotic therapy have risks and benefits. In an article in this month’s issue of Annals of Long-Term Care, William Smucker, MD, discusses the new oral anticoagulants that have been introduced into antithrombotic therapy, as well as an update on safety and evidence-based treatments for atrial fibrillation. You can find the full article here >>
For more information about anticoagulation in Long-Term Care, check out this article from our archives.